Spinal cord injury (SCI) remains a major clinical challenge due to the limited regenerative capacity of the central nervous system (CNS). Effective scaffolds for repair must combine mechanical compatibility with host tissue, controlled degradation matching the time course of regeneration, and microarchitectural features that promote neuronal survival. Electrospun nanofibrous scaffolds mimic the structural and mechanical features of the extracellular matrix, providing critical cues for neuronal adhesion and glial modulation in neural regeneration. Here, we fabricated biodegradable poly(lactic acid)/poly(ε-caprolactone) (PLA/PCL) scaffolds using a dichloromethane/tetrahydrofuran (DCM/THF) solvent system to induce surface porosity via solvent-driven phase separation. The DCM/THF solvent system formulation produced nanofibers with porous surfaces and increased area for cell interaction. PLA/PCL scaffolds showed a Young’s modulus of ~26 MPa and sustained degradation, particularly under oxidative conditions simulating the post-injury microenvironment. In vitro, these scaffolds enhanced neuronal density up to fivefold and maintained ~80% viability over 10 days in primary neuron–glia cultures. Morphometric analysis revealed that DCM/THF-based scaffolds supported astrocytes with preserved process complexity and reduced circularity, indicative of a less reactive morphology. In contrast, scaffolds fabricated with 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) displayed reduced bioactivity and promoted morphological features associated with astrocyte reactivity, including cell rounding and process retraction. These findings demonstrate that solvent-driven control of scaffold microarchitecture is a powerful strategy to enhance neuronal integration and modulate glial morphology, positioning DCM/THF-processed PLA/PCL scaffolds as a promising platform for CNS tissue engineering.
1 September 2024 in Journal of Evolutionary Biochemistry and Physiology
The serotonergic system plays an essential role in the modulation of the spinal network activity involved in the control of motor, sensory, and visceral functions. Spinal cord injury (SCI) can induce a state of overexcitation that contributes to pain, spasticity, and autonomic dysfunction. At the same time, serotonergic axons are known to adapt to pathophysiological changes faster than the other axons and retain the ability to sprout and regenerate after injury. A number of experimental animal studies, as well as some clinical observations, suggest that the serotonergic system is a key endogenous resource for posttraumatic recovery after SCI. Specific therapy may include the administration of serotonergic drugs and intraspinal transplantation of serotonergic neurons. This review addresses the role of the serotonergic system in functional recovery after SCI and the prospects for the use of serotonergic drugs in neurorehabilitation.
1 July 2025 in Journal of Evolutionary Biochemistry and Physiology
The article provides a summary and critical analysis of literature data, primarily from the last five years, on neural interfaces. It overviews experimental findings and clinical outcomes from applying neural interfaces for the enhancement of human capabilities in interacting with the environment. It also illustrates how employing the latest advancements in electronics, nanoscale bioengineering, and artificial intelligence improves quality of life or can be utilized for the purposes of regenerative medicine. The review highlights the most promising types of neural interfaces, with a particular emphasis on invasive technologies and the use of cutting-edge developments in implantable materials with high biocompatibility, durability, and optimized biophysical properties. Materials for invasive technologies are evaluated in the light of their applicability for specific biomedical purposes, accompanied by a comparative analysis. Significant attention is paid to the latest technologies in the fields of biomimetics and electrical biostimulation, as well as innovative approaches to the applied aspects of brain and spinal interfaces. Thus, this review serves as a valuable source of information for students and professionals whose educational and professional interests are aimed at diving deeper into the world of neural interfaces.
Elastin Microfibril Interface Located Protein 1 (EMILIN-1) is a multifunctional extracellular glycoprotein, primarily involved in maintaining tissue homeostasis. Known for regulation of elastogenesis and vascular stability, EMILIN-1 has emerged as a key modulator of multiple biological processes, including cell adhesion, migration, and proliferation. Recent experimental data highlight the importance of EMILIN-1 in cancer biology, especially in malignant tumors of the nervous system, where EMILIN-1’s regulatory functions influence tumor progression and metastatic potential. Specifically, EMILIN-1 can exert tumor-suppressive effects by modulating cell signaling pathways of tumor cells and EMILIN-1 can also alter the immune response and promote progression of brain tumors. This review article provides a comprehensive analysis of the recently discovered mechanisms through which EMILIN-1 promotes tumor progression in the nervous system and other sites.
1 December 2024 in Journal of Evolutionary Biochemistry and Physiology
Spinal cord injury (SCI) is a complex pathology with a multifaceted pathogenesis and, to date, no definitive treatment strategy. Among emerging therapeutic approaches, a combination strategy leveraging biomaterial-based scaffolds for the delivery of both cells and therapeutic agents to the injured spinal cord has shown significant promise. While standalone cell therapies often demonstrate limited efficacy, biomaterial scaffolds can protect transplanted cells from the hostile microenvironment of the injury site and provide a supportive matrix for cell adhesion and subsequent integration into the host neural tissue. Contemporary approaches in cell and organoid therapy, combined with smart biomaterials that can dynamically adapt their properties in response to specific stimuli, present unprecedented opportunities for SCI treatment. This review aims to provide a comprehensive overview of the recent advances in SCI therapies involving cell transplantation and biomaterial scaffolds, with a particular focus on their combinations. It highlights the strengths and limitations of different types of cell transplantation, including less conventional approaches, discusses brain organoid transplantation methods, and identifies the most frequently used scaffold types selected based on their mechanical properties and 3D architecture.
Phosphorylation of the STAT1 protein at serine 727 position (pSTAT1_S727) is a key posttranslational modification. Its function in the anti-tumor immune response within malignant central nervous system (CNS) tumors remains poorly understood. This study aimed to determine the role of pSTAT1_S727 for anticancer immune modulation in glioblastoma, the most aggressive brain tumor. Our results have shown that STAT1_S727 phosphorylation is closely associated with activation of the anti-tumor immune system. A positive correlation was found between pSTAT1_S727 levels and expression of genes encoding components of the major histocompatibility complex class I ( MHC-I ), as well as other genes involved in tumor antigen presentation. This finding indicates that pSTAT1_S727 plays an important role in enhancing the antigen-presenting capacity of glioblastoma cells, a critical step for tumor recognition by the immune system. Furthermore, high levels of pSTAT1_S727 did significantly correlate with increased intensity of tumor infiltration by cytotoxic CD8 + T cells. These observations were consistently confirmed both by the results from glioblastoma patients, and in experimental murine models, tgus underscoring the significance of this relationship. Hence, the STAT1_ S727 phosphorylation has been considered an important molecular factor promoting the initiation of immune recognition of glioblastoma by enhancing antigen presentation and recruiting effector T cells. However, despite this pro-inflammatory role, the clinical follow-up of patients did not reveal an association between high pSTAT1_S727 levels and improved overall survival. This lack of clinical benefit may be explained by the highly immunosuppressive microenvironment of glioblastoma, with functional exhaustion of infiltrating T cells, thus facilitating the tumor evasion effects. Therefore, activation of the pSTAT1_S727 signaling pathway is necessary for initiating an immune response. However, its action is insufficient to overcome immunosuppression and achieve a significant therapeutic effect. The obtained data highlight the need for combined strategies that enhance the initiation of immune response (e.g., through STAT1 activation), along with blocking the mechanisms of T cell exhaustion within the tumor microenvironment.